351. Modeling Genomic Imprinting Disorders Using Induced Pluripotent Stem Cells.
- Author
-
Chamberlain SJ, Germain ND, Chen PF, Hsiao JS, and Glatt-Deeley H
- Subjects
- Alleles, Animals, Cell Differentiation, Cells, Cultured, DNA Copy Number Variations, DNA Methylation, DNA Primers chemical synthesis, DNA Primers metabolism, Feeder Cells cytology, Fibroblasts cytology, Humans, In Situ Hybridization, Fluorescence methods, Induced Pluripotent Stem Cells pathology, Mice, Polymerase Chain Reaction methods, Prader-Willi Syndrome diagnosis, Prader-Willi Syndrome pathology, RNA genetics, RNA metabolism, RNA, Small Nucleolar genetics, RNA, Small Nucleolar metabolism, Ubiquitin-Protein Ligases genetics, Ubiquitin-Protein Ligases metabolism, Epigenesis, Genetic, Genomic Imprinting, Induced Pluripotent Stem Cells metabolism, Models, Genetic, Prader-Willi Syndrome genetics
- Abstract
Induced pluripotent stem cell (iPSC) technology has allowed for the invaluable modeling of many genetic disorders including disorders associated with genomic imprinting. Genomic imprinting involves differential DNA and histone methylation and results in allele-specific gene expression. Most of the epigenetic marks in somatic cells are erased and reestablished during the process of reprogramming into iPSCs. Therefore, in generating models of disorders associated with genomic imprinting, it is important to verify that the imprinting status and allele-specific gene expression patterns of the parental somatic cells are maintained in their derivative iPSCs. Here, we describe three techniques: DNA methylation analysis, allele-specific PCR, and RNA FISH, which we use to analyze genomic imprinting in iPSC models of neurogenetic disorders involving copy number variations of the chromosome 15q11-q13 region.
- Published
- 2016
- Full Text
- View/download PDF